ARA-290

ARA-290: Cibinetide, an erythropoietin-derived peptide studied in tissue-protective signalling.

What is it?

Cibinetide, an erythropoietin-derived peptide studied in tissue-protective signalling.

How it is studied

Its design explores tissue-related receptor effects separately from erythropoietin’s stimulation of red-blood-cell production.

What the evidence says

Small clinical programmes investigated neuropathic symptoms and nerve-fibre measures in selected populations. Findings varied across studies and outcomes.

What remains uncertain

Early signals do not establish a general nerve-repair treatment. Long-term safety needs stronger evidence, and a research vial is not interchangeable with a trial formulation.

Sources & scope

Small-fiber neuropathy pilot in sarcoidosis (2012)

For in-vitro laboratory research only. Not for human or veterinary use.